Protalix BioTherapeutics (PLX) Payables (2009 - 2026)
Protalix BioTherapeutics' Payables came in at $6.51 million for Q2 2026, down 2.7% from $6.69 million a year earlier but up 51.8% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Protalix BioTherapeutics' Payables was $5.26 million, up 16.0% from FY2024.
- Payables carries a five-year compound annual growth rate of -14.2% (FY2020 to FY2025).
- Going back by year, Payables was $4.53 million in FY2024 (+4.9%), $4.32 million in FY2023 (-26.3%), $5.86 million in FY2022 (-16.1%) and $6.99 million in FY2021 (-38.2%).
- The five-year range for quarterly Payables is $3.11 million (Q3 2023) to $8.44 million (Q3 2021).
- Year-over-year, Payables increased in seven of the last eight quarters, with growth averaging 23.7%.
- The fastest year-over-year change in Payables over five years came in Q3 2025 (growth of 71.5%), and the weakest in Q2 2023 (a decline of 52.7%).
- Business Quant data shows PLX's Payables at $4.29 million (Q1 2026), $5.26 million (Q4 2025) and $5.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Protalix BioTherapeutics | 230.43 Mn | 59.88 Mn | 14.05 Mn | 4.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.78 Mn |
| Jun 30, 2026 | 6.51 Mn |
| Mar 31, 2026 | 4.29 Mn |
| Dec 31, 2025 | 5.26 Mn |
| Sep 30, 2025 | 5.38 Mn |
| Jun 30, 2025 | 6.69 Mn |
| Mar 31, 2025 | 4.12 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 4.06 Mn |
| Mar 31, 2024 | 3.15 Mn |
| Dec 31, 2023 | 4.32 Mn |
| Sep 30, 2023 | 3.11 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 5.11 Mn |
| Dec 31, 2022 | 5.86 Mn |
| Sep 30, 2022 | 5.64 Mn |
| Jun 30, 2022 | 6.99 Mn |
| Mar 31, 2022 | 7.87 Mn |
| Dec 31, 2021 | 6.99 Mn |
API Access
Protalix BioTherapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();